Twin, Test, Treat: Brain Therapy made Predictable.
VB Tech provides digital twin brain simulations to support clinicians and researchers in exploring brain function, understanding pathological mechanisms, and evaluating potential interventions.
Our mission is to develop simulation-based tools that integrate patient data to support more informed clinical and research decisions.
VB Tech combines its Virtual Brain Twin technology with novel non-invasive neurostimulation approaches to support clinical and research applications in neurology.
This integrated platform offers a new way to model, test, and understand brain function in both health and disease.
The medical challenge
Brain disease care is highly complex due to patient variability and limitations of current diagnostic and treatment approaches Traditional methods rely on indirect biomarkers, subjective clinical interpretation, and often invasive procedures, leading to diagnostic uncertainty and inadequate therapeutic decisions.
Brain diseases face a critical unmet need for precise, personalized, and predictive tools, limiting treatment optimization and patient outcomes.
For instance, in drug-resistant epilepsy (30%), identifying the seizure epicenters remains imprecise and incomplete, resulting in 40% failed surgeries.
- 1 in 8 people affected by brain diseases
- This accounts for 1/3 of global healthcare spending and causes 6.8 million deaths per year. As the population ages, these figures are bound to increase even further.
- 50 million people affected by epilepsy
- 30% of epilepsy patients are drug-resistant (DRE). Epilepsy care accounts for $120 billion in healthcare costs per year.
